Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audinga-Dea Hazewinkel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Computational and Mathematical Methods in Medicine|October 14, 2022
Neural Networks for Survival Prediction in Medicine Using Prognostic Factors: A Review and Critical AppraisalGeorgios Kantidakis, Audinga-Dea Hazewinkel, Marta Fiocco
Current Oncology (Toronto, Ont.)|July 26, 2024
Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial DataMarta Spreafico, Audinga-Dea Hazewinkel, Hans Gelderblom, et al.
Biometrical Journal. Biometrische Zeitschrift|September 20, 2023
Trial arm outcome variance difference after dropout as an indicator of missing-not-at-random bias in randomized controlled trialsAudinga-Dea Hazewinkel, Kate Tilling, Kaitlin H Wade, et al.
Economics and Human Biology|December 11, 2021
Mendelian randomization analysis of the causal impact of body mass index and waist-hip ratio on rates of hospital admissionAudinga-Dea Hazewinkel, Rebecca C Richmond, Kaitlin H Wade, et al.
Statistics in Medicine|January 31, 2022
Sensitivity to missing not at random dropout in clinical trials: Use and interpretation of the trimmed means estimatorAudinga-Dea Hazewinkel, Jack Bowden, Kaitlin H Wade, et al.
Cancers|August 29, 2024
Machine Learning versus Cox Models for Predicting Overall Survival in Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial DataMarta Spreafico, Audinga-Dea Hazewinkel, Michiel A J van de Sande, et al.
BMJ Open|March 5, 2022
Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trialAudinga-Dea Hazewinkel, Carlo Lancia, Jakob Anninga, et al.
Stroke|October 2, 2024
Use of the Win Ratio for Analysis of Stroke Trials: Description, Illustration, and Planned Use in the Second European Carotid Surgery Trial (ECST-2)John Gregson, Simone J A Donners, Diederik Dippel, et al.
Journal of the American College of Cardiology|June 11, 2025
Re-Evaluating Recurrent Events in Heart Failure Trials: Patterns, Prognostic Implications, and Analytical ImprovementsAudinga-Dea Hazewinkel, John Gregson, Stuart J Pocock, et al.
The Lancet. Neurology|April 19, 2025
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trialSimone J A Donners, Twan J van Velzen, Suk Fun Cheng, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Computational and Mathematical Methods in Medicine|October 14, 2022
Neural Networks for Survival Prediction in Medicine Using Prognostic Factors: A Review and Critical AppraisalGeorgios Kantidakis, Audinga-Dea Hazewinkel, Marta Fiocco
Current Oncology (Toronto, Ont.)|July 26, 2024
Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial DataMarta Spreafico, Audinga-Dea Hazewinkel, Hans Gelderblom, et al.
Biometrical Journal. Biometrische Zeitschrift|September 20, 2023
Trial arm outcome variance difference after dropout as an indicator of missing-not-at-random bias in randomized controlled trialsAudinga-Dea Hazewinkel, Kate Tilling, Kaitlin H Wade, et al.
Economics and Human Biology|December 11, 2021
Mendelian randomization analysis of the causal impact of body mass index and waist-hip ratio on rates of hospital admissionAudinga-Dea Hazewinkel, Rebecca C Richmond, Kaitlin H Wade, et al.
Statistics in Medicine|January 31, 2022
Sensitivity to missing not at random dropout in clinical trials: Use and interpretation of the trimmed means estimatorAudinga-Dea Hazewinkel, Jack Bowden, Kaitlin H Wade, et al.
Cancers|August 29, 2024
Machine Learning versus Cox Models for Predicting Overall Survival in Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial DataMarta Spreafico, Audinga-Dea Hazewinkel, Michiel A J van de Sande, et al.
BMJ Open|March 5, 2022
Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trialAudinga-Dea Hazewinkel, Carlo Lancia, Jakob Anninga, et al.
Stroke|October 2, 2024
Use of the Win Ratio for Analysis of Stroke Trials: Description, Illustration, and Planned Use in the Second European Carotid Surgery Trial (ECST-2)John Gregson, Simone J A Donners, Diederik Dippel, et al.
Journal of the American College of Cardiology|June 11, 2025
Re-Evaluating Recurrent Events in Heart Failure Trials: Patterns, Prognostic Implications, and Analytical ImprovementsAudinga-Dea Hazewinkel, John Gregson, Stuart J Pocock, et al.
The Lancet. Neurology|April 19, 2025
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trialSimone J A Donners, Twan J van Velzen, Suk Fun Cheng, et al.
Pageof 1